Newsroom

Back
  • Newsroom
    • For Journalists
    • Request to Film on Campus
    • Archived News

    Newly discovered pathway fuels production of cancer-driving proteins

    October 28, 2026

    Researchers identified a previously unknown mechanism that helps cancer cells produce cancer-promoting proteins, including KRAS Blocking a specific enzyme reduced tumor growth in preclinical models of common cancer types Loss of the enzyme also improved response to KRAS-targeted drugs and counteracted treatment resistance The findings suggest this enzyme could be a target for KRAS-driven cancers

    A previously unknown mechanism helps...

    Read More

    AI tool reveals what attracts immune cells to tumors and what keeps them away

    BY Julie Nagy

    October 13, 2026

    Researchers developed a new artificial intelligence (AI) tool that can help explain where immune cells gather in the body and what guides them...
    Read More

    Researchers suggest tile-based radiation therapy as standard of care to lower risk of recurrence in brain metastases

    BY Julie Nagy

    September 28, 2026

    A type of radiation treatment implanted during surgery (GammaTile) significantly lowers risk of recurrence and may help patients with brain...
    Read More

    Researchers uncover dual role of B7-H3 in tumor immune suppression

    September 22, 2026

    Researchers identified a previously unknown pathway for the B7-H3 immune checkpoint that creates a physical defense for prostate tumors Using a therapy to target B7-H3 along with a MEK inhibitor targeting this pathway produced durable antitumor activity in preclinical models of advanced prostate cancer Findings uncovered a novel biological function of B7-H3 in cancer immunity Results suggest a combination approach could overcome treatment...
    Read More

    B cells may help predict risk of colitis from immunotherapy

    BY Julie Nagy

    September 18, 2026

    Colitis, an inflammation of the inner lining of the colon, is a common side effect of immunotherapy that can disrupt treatment No methods currently...
    Read More

    UT MD Anderson and Nature to co-host conference on next-generation cancer therapeutics

    BY Julie Nagy

    September 15, 2026

    In-person conference runs Oct. 6-8, 2026, with registration open until Oct. 5, 2026 Topics include next-generation cancer therapeutics and immunotherapies...
    Read More

    Blood test could monitor bone metastasis in medullary thyroid cancer

    BY Julie Nagy

    September 08, 2026

    Medullary thyroid cancer often spreads to the bone in advanced disease, causing abnormal bone growth Researchers discovered the OPG protein...
    Read More

    Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical models

    BY Julie Nagy

    September 03, 2026

    Peripheral neuropathy is a common side effect of chemotherapy treatment, resulting in symptoms that can include numbness, painful nerve injury...
    Read More

    Researchers identify new way to reduce chronic nerve pain

    BY Julie Nagy

    August 24, 2026

    Study reveals the BRAF protein, commonly linked to cancer, may also drive chronic nerve pain After nerve injury, BRAF triggers changes that...
    Read More

    Colorectal cancer may quietly damage nerves prior to chemotherapy

    BY Julie Nagy

    August 19, 2026

    Researchers at The University of Texas MD Anderson Cancer Center found that, in preclinical models of colorectal cancer, tumors can start...

    Read More
    More

    Help #EndCancer

    Give Now

    Your gift will help make a tremendous difference.
    Donate

    Donate Blood

    Our patients depend on blood and platelet donations.

    Make an appointment

    Shop UT MD Anderson

    Show your support for our mission through branded merchandise. 

    View products
    Subscribe to our Cancerwise newsletter
    UT MD Anderson logoUT MD Anderson logo
    • Explore
    • Patients & Family
    • Prevention & Screening
    • Donors & Volunteers
    • For Physicians
    • Research
    • Education & Training
    • Clinical Trials
    • Languages
    • About
    • About UT MD Anderson
    • Careers
    • Blog
    • Newsroom
    • Editorial Standards
    • For Employees
    • Merchandise
    • Title IX Reporting (Sexual Misconduct)
    • Price Transparency
    • Finding Your Way
    • Our Doctors
    • Locations
    • Directions
    • Sitemap
    • DIGITAL ACCESSIBILITY
    • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
    • GET IN TOUCH
    • Call
      1-877-632-6789
    • Ask a question
    • Stay Connected
    • Cancerwise Podcast
    • More
    • Website Privacy Policy
    • Legal Statement & Policies
    • Reports to the State
    • Emergency Alert Information
    • State of Texas Links
    • Our Cancer Network
    • Vendors & Suppliers
    UT MD Anderson logo
    The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

    © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

    Top